The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real world effectiveness of systemic treatment in patients (pts) with advanced upper tract urothelial carcinoma (UTUC) with histological variants.
 
Fabien Moinard-Butot
Honoraria - Bristol-Myers Squibb
 
Karim Amrane
No Relationships to Disclose
 
Luca Campedel
No Relationships to Disclose
 
Damien Pouessel
Honoraria - AAA/Endocyte/Novartis; Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Ipsen; MSD Oncology; Pfizer/Astellas
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb/Medarex; Eisai; Merck; MSD Oncology; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst); Roche (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen Oncology; Pfizer
 
Mostefa Bennamoun
No Relationships to Disclose
 
Aude Flechon
Honoraria - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; Gilead Sciences; Ipsen; Janssen-Cilag; MSD Oncology; NOVARTIS; PFIZER; Roche/Genentech; Sanofi/Aventis
Travel, Accommodations, Expenses - AAA HealthCare; Astellas Pharma; AstraZeneca; Bayer; BMS; IPSEN; Janssen-Cilag; MSD Oncology; Pfizer; Roche/Genentech; Sanofi/Aventis
 
Matthieu Roulleaux Dugage
No Relationships to Disclose
 
Pierre-Etienne Gabriel
No Relationships to Disclose
 
Constance Thibault
Honoraria - AAA/Endocyte/Novartis; Accord Healthcare; Amgen; Astellas Pharma; AstraZeneca; Bristol Myers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer; Sanofi; Seagen
Consulting or Advisory Role - AAA/Endocyte/Novartis; AstraZeneca; Bristol-Meyers Squibb; Gilead Sciences; Ipsen; Janssen Oncology; Merck; MSD Oncology; Pfizer
Research Funding - AstraZeneca (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Janssen Oncology; MSD Oncology; Pfizer
 
Baptiste Abbar
Honoraria - Astellas Oncology; AstraZeneca; BMS Brazil; MSD; Novartis; Sanofi
Research Funding - MSD Avenir
Travel, Accommodations, Expenses - Ipsen; Janssen; MSD; Pfizer
 
Jean-Baptiste Barbe-Richaud
No Relationships to Disclose
 
Clement Dumont
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Merck Serono; MSD; Pfizer
Travel, Accommodations, Expenses - Ipsen; Janssen; Janssen; MSD; Pfizer
 
Philippe Barthelemy
Honoraria - Astellas Oncology; AstraZeneca; Bristol-Myers Squibb; Janssen; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Janssen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; MSD; Pfizer